BioRem Current Deferred Revenue from 2010 to 2024

Stocks . Canada . 
Stock . BioRem Inc
BRM Stock  CAD 3.00  0.02  0.67%   
BioRem Current Deferred Revenue yearly trend continues to be fairly stable with very little volatility. Current Deferred Revenue is likely to outpace its year average in 2024. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2005-12-31
Previous Quarter
4.6 M
Current Value
6.2 M
Quarterly Volatility
1.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 281.4 K, Total Revenue of 18.5 M or Gross Profit of 5.5 M, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 2.89. BioRem financial statements analysis is a perfect complement when working with BioRem Valuation or Volatility modules.
  
This module can also supplement various BioRem Technical models . Check out the analysis of BioRem Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY